As a cancer research scientist and cancer survivor, here are the top five topics that I'll be looking out for.
By growing cells in unrealistic liquids, they may have inadvertently skewed the results of their experiments.
Scientists say it’s crucial to make long-term connections with study participants if they want to get the data they need.
Imagine that your job is to put together an edgeless, 1,000-piece jigsaw puzzle. But you have no corner pieces to guide you, and you have no idea what the final puzzle is supposed to look like. You can only find out if you’re right by running a test on each attempt, which will tell you whether or not you’ve struck the right combination.
Scientists working on ways to combat dangerous cancers are exploring a treatment path that may wind up being as simple as feeling happy thoughts.
Right now it’s only being tested on mice, but a new study adds to a growing body of research that suggests we might one day be able to treat cancer by triggering a primary reward region in the brain.
Healthy cells carry a surprising number of cancer-linked mutations, but they don’t turn into tumors. What’s holding them back?
Giusti has inspired other patients to follow her. “She has truly moved mountains in the multiple myeloma field and set an example of what’s possible for the role patients can play,” says Josh Sommer, 30, the executive director and cofounder of the Chordoma Foundation and a Forbes 30 Under 30 alumnus.
James Allison and Tasuku Honjo advanced immunotherapy — and gave patients with cancer new hope.
“Non-inferiority” trials are arguably our most powerful weapon in the war against unnecessary or harmful pharmaceuticals.
I'll be the first to admit that despite all the billions put into cancer research, the end results of preventing cancer and treating advanced cancer have been disappointing.
Unlike reducing deaths from heart attacks and stroke, progress in reducing deaths from cancer has been disappointingly slow.
Pres. Obama laid out a moon-shot target of knocking out cancer, but cancer is not one disease—it’s many.
Understanding how the disease evolves is the key to stopping it.
Dr. Varmus, whose last day at the cancer institute is Tuesday, recently reflected on financial constraints in science, the fight against cancer and his own efforts to remain healthy. Our interview has been condensed and edited for space.
Where are the cures promised by stem cells, gene therapy, and the human genome?
Cancer is not just one disease; it is many.The latest advances in genetics, immunology and cellular biology are paving the way to better treatments (and perhaps even a few cures) for all of them
Cancer’s most promising therapies come with $100,000-plus price tags.
We are a charity that funds research into any type of cancer anywhere in the world.
We fund projects in the world’s best research institutions. Some of the world’s most diverse and unexpected projects. We fund world-renowned specialists and up and coming talent.
Exploring progress in cancer research from the patient perspective. I'm a cancer research advocate who was diagnosed with breast cancer in 1993 at the age of 35. I'm a graduate of the National Breast Cancer Coalition's Project LEAD program, which trains advocates in the fundamentals of breast cancer science. I've also served on numerous panels reviewing cancer research proposals for government funding. Please join us as we follow the progress that's being made in cancer research, care and prevention.
The Cancer Research Institute (CRI) is the world's only nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. This important work has led to a promising new class of cancer treatments called cancer immunotherapy. These treatments mobilize, strengthen, and sustain the immune system's natural ability to destroy cancer cells, wherever they are in the body.
The Center for Cancer Research (CCR) is home to more than 250 scientists and clinicians working in intramural research at NCI. CCR is organized into over 50 branches and laboratories, each one grouping scientists with complementary interests. CCR's investigators are basic, clinical, and translational scientists who work together to advance our knowledge of cancer and AIDS and to develop new therapies against these diseases.
The mission of the Prevent Cancer Foundation is cancer prevention and early detection through research, education and community outreach to all populations, including children and the underserved.
The Cancer Letter, published weekly since its founding, keeps clinical and academic oncologists, cancer researchers, and patient advocates current with government grant opportunities and research plans, industry news, and advocacy activities.
Current Advances in Cancer Research is a monthly current literature searching service which is fast, comprehensive, economical and easy to use. It enables pure and applied scientists to keep abreast of the ever-increasing literature being published in their subject area.
The AACR is the authoritative source of information about advances in the causes, diagnosis, treatment and prevention of cancer. By accelerating the growth and spread of new knowledge about cancer, the AACR is on the front lines of the quest for prevention and cure.
30 years ago, the American Institute for Cancer Research was founded on a simple but radical idea: everyday choices can reduce our chances of getting cancer.
We were the first organization to focus research on the link between diet and cancer and translate the results into practical information for the public. AICR embraced the mission of changing lives to save lives.
Cancer Research publishes significant, original studies in all areas of basic, clinical, translational, epidemiological, and prevention research devoted to the study of cancer and cancer-related biomedical sciences.
Cancer is common '' around 285,000 new cases are diagnosed each year in the UK. At Cancer Research UK we are working hard to improve our understanding of cancer and develop better ways to prevent, diagnose and treat the disease.
The Eppley Institute for Research in Cancer and Allied Diseases is a multidisciplinary cancer research institute at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska.
The Fels Institute for Cancer Research and Molecular Biology was founded in 1933 by Philadelphia industrialist and philanthropist Samuel S. Fels, who was President of Fels & Company, manufacturer of the vastly popular household soap, Fels Naptha.
At Fred Hutchinson Cancer Research Center, scientists have the freedom to conduct creative research that leads to lifesaving discoveries. Our world-renowned team has made significant breakthroughs related to cancer, HIV/AIDS and other diseases. Our pioneering research has saved hundreds of thousands of lives worldwide.
Genentech BioOncology is dedicated to fostering future progress in anticancer innovations by sharing the latest advances in cancer research.
The Ludwig Institute for Cancer Research is an international non-profit research institute dedicated to improving the understanding and control of cancer.
Molecular Cancer Research publishes original, novel, and well-designed studies on the molecular and cellular aspects of cancer biology.
Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology.
The MMRF relentlessly pursues innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure.
The National Foundation for Cancer Research was founded in 1973 to support cancer research and public education relating to the prevention, early diagnosis, better treatments and ultimately, a cure for cancer. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside.
Ovarian Cancer Research Fund (OCRF) is the largest private philanthropy in the United States dedicated exclusively to funding ovarian cancer research. Our mission is to fund scientific research that leads to more effective identification, treatment, and ultimately a cure for ovarian cancer.
RGI plans to continue its ongoing basic research as well as anti-cancer drug discovery and screening. Particular emphasis will be placed on research conducted with its unique human xenograft model and cell line that had won recognition for RGI in the past from the National Cancer Institute and various academic institutions.
Up to date breaking cancer news.
The Sidney Kimmel Foundation for Cancer Research is dedicated to improving the understanding of cancer biology and to developing new methods for the treatment and prevention of cancer.
Welcome to the home page of the Southwest Oncology Group, one of the largest of the National Cancer Institute-supported cancer clinical trials cooperative groups in the United States. Our primary mission is clinical research in the prevention and cure of cancer.
Brain tumour research is chronically underfunded in the UK, receiving less than 2% of all cancer research funding. Yet research is vital to improve treatments and diagnosis for the thousands of people diagnosed with a brain tumour each year, ultimately saving lives and improving quality of life.
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Scientists and clinicians at the ICR are working every day to make a real impact on cancer patients’ lives.
Today, we are ranked as the UK’s leading academic research centre, and lead the world at isolating cancer-related genes and discovering new targeted cancer drugs.
The TRDRP is administered by the University of California and is a program of the Research Grants Program Office (RGPO), Office of Research and Graduate Studies at the University of California, Office of the President. The Research Grants Program Office is led by Dr. Mary Croughan, Executive Director, who oversees a broad portfolio of research programs and grants, representing up to $100 million in funded research each year.